Literature DB >> 19109341

The place for harm reduction and product regulation in UK tobacco control policy.

Anna B Gilmore1, John Britton, Deborah Arnott, Richard Ashcroft, Martin J Jarvis.   

Abstract

Tobacco use remains the leading cause of preventable death in this country and more needs to be done to reduce smoking rates. Harm reduction is one policy option. Smokers smoke for the nicotine, but die from the other toxins in cigarette smoke. Harm reduction in tobacco control aims to reduce the harm arising from nicotine use by shifting smokers, who are unable to quit, to using far less hazardous sources of nicotine, notably medicinal nicotine, in place of cigarettes. This article argues that for harm reduction to work in the UK, a nicotine product regulation authority is first needed. This would regulate nicotine products in proportion to harm to ensure that, contrary to the current paradoxical arrangements, the most harmful source of nicotine, the cigarette, becomes the most highly regulated (and thus the least easily accessible, available and attractive). It goes onto explore how a harm reduction strategy might be further developed, exploring controversies and potential pitfalls. It argues that the public health community needs to own and drive this debate because failure to do so would let the tobacco industry gain the upper hand and see thousands of more unnecessary deaths from tobacco use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109341     DOI: 10.1093/pubmed/fdn105

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  6 in total

1.  The tobacco use management system: analyzing tobacco control from a systems perspective.

Authors:  Ron Borland; David Young; Ken Coghill; Jian Ying Zhang
Journal:  Am J Public Health       Date:  2010-05-13       Impact factor: 9.308

2.  The case for OFSMOKE: how tobacco price regulation is needed to promote the health of markets, government revenue and the public.

Authors:  Anna B Gilmore; J Robert Branston; David Sweanor
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

3.  Smoker interest in lower harm alternatives to cigarettes: national survey data.

Authors:  Nick Wilson; Ron Borland; Deepa Weerasekera; Richard Edwards; Marie Russell
Journal:  Nicotine Tob Res       Date:  2009-10-14       Impact factor: 4.244

4.  Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 1).

Authors:  Frank Lüdicke; Patrick Picavet; Gizelle Baker; Christelle Haziza; Valerie Poux; Nicola Lama; Rolf Weitkunat
Journal:  Nicotine Tob Res       Date:  2018-01-05       Impact factor: 4.244

5.  Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2).

Authors:  Christelle Haziza; Guillaume de La Bourdonnaye; Andrea Donelli; Dimitra Skiada; Valerie Poux; Rolf Weitkunat; Gizelle Baker; Patrick Picavet; Frank Lüdicke
Journal:  Nicotine Tob Res       Date:  2020-04-17       Impact factor: 4.244

6.  Protocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokers.

Authors:  Doug Fraser; Ron Borland; Coral Gartner
Journal:  BMC Public Health       Date:  2015-10-06       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.